Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.

Journal of cellular and molecular medicine - 1 Nov 2020

Liu Zijian, Mi Mi, Li Xiaoqian, Zheng Xin, Wu Gang, Zhang Liling

Abstract excerpt

Current studies have shown that long non-coding RNAs (lncRNAs) may serve as prognostic biomarkers in multiple cancers. Therefore, we postulated that expression patterns of multiple lncRNAs combined into a single signature could improve clinicopathological risk stratification and prediction of overall survival rate for breast cancer patients. Two algorithms, Least Absolute Shrinkage and Selector Operation (LASSO)...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immune System
Share to Kaplan-Meier Estimate

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Multivariate Analysis

Share to Nomograms

Share to Predictive Value of Tests

Share to Proportional Hazards Models

Share to RNA, Long Noncoding

Share to Support Vector Machine

Source

Open in PubMed Open full text

Identifiers

PMID: 32967061
DOI: 10.1111/jcmm.15762
PMCID: PMC7687003

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A lncRNA prognostic signature associated with immune infiltration and tumour mutation burden in breast cancer.PMID 32967061Read ↗

Identification of a Six-Immune-Related Long Non-coding RNA Signature for Predicting Survival and Immune Infiltrating Status in Breast CancerSemantic proximity Read ↗

Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signatureSemantic proximity Read ↗

Development of an Immune-Related Prognostic Signature in Breast CancerSemantic proximity Read ↗

Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Estrogen Receptor (ER) or Progesterone Receptor (PR) Positive and Human Epidermal Growth Factor Receptor 2 (HER2) Negative Breast CancerSemantic proximity Read ↗

Identification and Validation of Immune-Related Gene Prognostic Signature for breast cancerSemantic proximity Read ↗

Construction of Prognostic Signature of Breast Cancer Based on N7-Methylguanosine-Related LncRNAs and Prediction of Immune ResponseSemantic proximity Read ↗

Identification of Prognostic Immune-Related lncRNAs Pairs in Immune Infiltration of Breast CancerSemantic proximity Read ↗

Construction and Validation of Immune-Related LncRNA Signature to Predict the Prognosis and Therapeutic Efficacy of Breast CancerSemantic proximity Read ↗

Immune cell infiltration-based signature for prognosis and immunogenomic analysis in breast cancer.Semantic proximity Read ↗

Construction of a Six Immune-Related lncRNAs Signature to Predict Outcome, Immune Cell Infiltration and Immunotherapy Response in Patients with Hepatocellular CarcinomaSemantic proximity Read ↗

Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancerSemantic proximity Read ↗

Construction of a prognostic 6-gene signature for breast cancer based on multi-omics and single-cell dataSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.